Sort
25,944 grants matching “neurodegeneration”
NDC for the Optical Control of Biological Function
$5,000,000Ehud Isacoff · University Of California Berkeley · PN2 · FY2012 · EY
PET Radiopharmaceutical Sciences
$4,988,594Victor W Pike · National Institute Of Mental Health · ZIA · FY2022 · MH
APOE in the Predisposition to, Protection from and Prevention of Alzheimer's Disease
$4,963,475Eric M Reiman · Banner Health · R01 · FY2024 · AG
A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease
$4,951,060Richard C. Mohs · Agenebio, Inc. · R01 · FY2018 · AG
A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease
$4,948,571Richard C. Mohs · Agenebio, Inc. · R01 · FY2019 · AG
A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease
$4,942,354Richard C. Mohs · Agenebio, Inc. · R01 · FY2020 · AG
A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease
$4,903,985Richard C. Mohs · Agenebio, Inc. · R01 · FY2020 · AG
NDC for the Optical Control of Biological Function
$4,877,000Ehud Isacoff · University Of California Berkeley · PN2 · FY2014 · EY
APOE in the Predisposition to, Protection from and Prevention of Alzheimer's Disease
$4,871,903Eric M Reiman · Banner Health · R01 · FY2025 · AG
Study of Healthy Aging in African Americans
$4,846,194Rachel A Whitmer · University Of California At Davis · R01 · FY2024 · AG
Massachusetts Alzheimer's Disease Research Center (MADRC)
$4,832,741Teresa Gomez-Isla · Massachusetts General Hospital · P30 · FY2024 · AG
Massachusetts Alzheimer's Disease Research Center (MADRC)
$4,825,067Teresa Gomez-Isla · Massachusetts General Hospital · P30 · FY2025 · AG
Mechanisms, modeling and therapies of retinal and macular neurodegeneration
$4,780,891Anand Swaroop · National Eye Institute · ZIA · FY2025 · EY
PET Radiopharmaceutical Sciences
$4,765,174Victor W Pike · National Institute Of Mental Health · ZIA · FY2023 · MH
Integrative Multi-Omic Discovery of Proximal Mechanisms Driving Age-Dependent Neurodegeneration
$4,760,794Mel B Feany · Brigham And Women'S Hospital · RF1 · FY2017 · AG
The Neighborhoods Study: Contextual Disadvantage and Alzheimerâs Disease and Related Dementias (ADRD)
$4,760,115Amy J. Kind · University Of Wisconsin-Madison · R01 · FY2021 · AG
Alzheimer's Disease Research Center
$4,750,237Scott A Small · Columbia University Health Sciences · P30 · FY2025 · AG
Study of Healthy Aging in African Americans
$4,747,819Rachel A Whitmer · University Of California At Davis · R01 · FY2025 · AG
Mount Sinai Alzheimer's Disease Research Center
$4,736,863Mary Sano · Icahn School Of Medicine At Mount Sinai · P30 · FY2025 · AG
Human Biochemical Genetics
$4,714,987William Gahl · National Human Genome Research Institute · ZIA · FY2018 · HG
Procurement and Characterization of Postmortem Brain Tissue
$4,711,045Stefano Marenco · National Institute Of Mental Health · ZIC · FY2023 · MH
Defining the molecular spectrum of white matter vascular lesions
$4,693,249Jason D Hinman · University Of California Los Angeles · RF1 · FY2024 · NS
Proteomic and Genetic Approaches Defining Apolipoprotein E4 Neuropathologic Mechanisms
$4,669,193Robert W. Mahley · J. David Gladstone Institutes · RF1 · FY2019 · AG
Human Biochemical Genetics
$4,658,970William Gahl · National Human Genome Research Institute · ZIA · FY2016 · HG
Study of Healthy Aging in African Americans
$4,646,209Rachel A Whitmer · University Of California At Davis · R01 · FY2023 · AG